RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: steatotic liver disease
Accession: DOID:9452
browse the term
Definition: A lipid storage disease characterized by the accumulation of large vacuoles of triglyceride fat in at least 5% of hepatocytes. (DO)
Synonyms: exact_synonym: SLD; fatty change of liver; fatty liver; fatty liver disease; hepatic lipidosis; hepatic steatosis; hepatosteatosis; liver steatoses; liver steatosis; steatohepatitides; steatohepatitis; steatosis of liver; visceral steatoses; visceral steatosis
narrow_synonym: cryptogenic steatotic liver disease
related_synonym: FATTY LIVER DISEASE, PROTECTION FROM; HSD17B13 POLYMORPHISM
primary_id: MESH:D005234
xref: EFO:0003934 ; ICD10CM:K70.0 ; ICD9CM:571.0 ; MONDO:0004790 ; NCI:C150596
GViewer not supported for the selected species.
G
Abca1
ATP binding cassette subfamily A member 1
treatment
ISO
associated with adult growth hormone deficiency
RGD
PMID:15995177 PMID:26362727 PMID:30130150
RGD:1598534 RGD:18936993 RGD:21408552
NCBI chrNW_004955419:21,553,863...21,681,626
Ensembl chrNW_004955419:21,553,835...21,681,619
G
Abcc2
ATP binding cassette subfamily C member 2
ISO
RGD
PMID:16139386
RGD:1598602
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
G
Abcc3
ATP binding cassette subfamily C member 3
ISO
mRNA, protein:increased expression:liver
RGD
PMID:17640958
RGD:2301064
NCBI chrNW_004955451:11,087,246...11,130,108
Ensembl chrNW_004955451:11,087,570...11,130,482
G
Acaca
acetyl-CoA carboxylase alpha
ISO
RGD
PMID:16485039
RGD:1625727
NCBI chrNW_004955451:679,033...909,892
Ensembl chrNW_004955451:600,254...909,892
G
Acacb
acetyl-CoA carboxylase beta
ISO
RGD
PMID:16485039
RGD:1625727
NCBI chrNW_004955455:10,282,308...10,427,439
Ensembl chrNW_004955455:10,308,192...10,426,076
G
Acat1
acetyl-CoA acetyltransferase 1
treatment
ISO
RGD
PMID:27813192
RGD:401842386
NCBI chrNW_004955412:10,350,088...10,369,806
Ensembl chrNW_004955412:10,349,593...10,369,806
G
Acox1
acyl-CoA oxidase 1
treatment
ISO
RGD
PMID:30298849
RGD:401960083
NCBI chrNW_004955506:6,286,824...6,309,764
Ensembl chrNW_004955506:6,286,648...6,312,716
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:plasma associated with hepatitis C;protein:increased expression:serum
RGD
PMID:16115302 PMID:17006986 PMID:20714777
RGD:1599139 RGD:5686674 RGD:5686883
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
G
Adipor2
adiponectin receptor 2
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:19076162 PMID:30225267
RGD:21406435 RGD:2307264
NCBI chrNW_004955454:4,243,898...4,327,255
Ensembl chrNW_004955454:4,243,898...4,327,308
G
Adk
adenosine kinase
ISO
OMIM:228100
MouseDO
NCBI chrNW_004955437:17,279,541...17,786,140
Ensembl chrNW_004955437:17,279,240...17,786,079
G
Adrb2
adrenoceptor beta 2
ISO
RGD
PMID:11718682
RGD:1559320
NCBI chrNW_004955415:5,515,157...5,517,198
Ensembl chrNW_004955415:5,515,697...5,516,980
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32045588
NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904
G
Alpl
alkaline phosphatase, biomineralization associated
ISO
associated with obesity
RGD
PMID:16197789
RGD:1601177
NCBI chrNW_004955452:1,820,212...1,873,877
Ensembl chrNW_004955452:1,820,174...1,874,226
G
Angptl4
angiopoietin like 4
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15837923 PMID:28842503
RGD:1625354
NCBI chrNW_004955563:1,024,163...1,030,816
Ensembl chrNW_004955563:1,021,414...1,029,894
G
Apoa1
apolipoprotein A1
treatment
ISO
RGD
PMID:30231880
RGD:25671436
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
G
Apob
apolipoprotein B
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver
CTD RGD
PMID:12048068 PMID:17203948 PMID:17303181
RGD:2325770
NCBI chrNW_004955469:3,437,422...3,478,408
Ensembl chrNW_004955469:3,436,450...3,478,424
G
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:29459263 PMID:32853627
RGD:13703129
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
Atf4
activating transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27664470
NCBI chrNW_004955413:25,406,589...25,408,727
Ensembl chrNW_004955413:25,406,589...25,412,218
G
Atf6
activating transcription factor 6
treatment
ISO
RGD
PMID:27813192
RGD:401842386
NCBI chrNW_004955462:14,352,956...14,553,299
Ensembl chrNW_004955462:14,357,945...14,548,543
G
Atp5if1
ATP synthase inhibitory factor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955452:7,372,917...7,375,072
Ensembl chrNW_004955452:7,373,001...7,375,856
G
Atp7b
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17303181
NCBI chrNW_004955431:5,228,395...5,297,120
Ensembl chrNW_004955431:5,229,126...5,269,616
G
Birc3
baculoviral IAP repeat containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21664615
NCBI chrNW_004955412:5,624,865...5,643,520
Ensembl chrNW_004955412:5,628,973...5,643,410
G
Ca3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955417:3,362,091...3,372,270
Ensembl chrNW_004955417:3,362,492...3,372,932
G
Cat
catalase
ISO
protein:decreased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10860543 PMID:21452373
RGD:5130871
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
G
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:liver
RGD
PMID:28011329
RGD:14995306
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
G
Cd36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:19788606
RGD:6893500
NCBI chrNW_004955410:5,003,720...5,120,903
Ensembl chrNW_004955410:5,003,668...5,075,313
G
Cebpb
CCAAT enhancer binding protein beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24469900
NCBI chrNW_004955445:8,060,432...8,061,289
G
Cndp2
carnosine dipeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955402:57,939,003...57,960,056
Ensembl chrNW_004955402:57,938,276...57,960,056
G
Col3a1
collagen type III alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15787813
NCBI chrNW_004955403:9,720,831...9,758,019
Ensembl chrNW_004955403:9,721,114...9,757,887
G
Cpe
carboxypeptidase E
ISO
mRNA:decreased expression:stomach (human)
RGD
PMID:24716593
RGD:405650681
NCBI chrNW_004955403:39,862,893...39,971,902
Ensembl chrNW_004955403:39,862,191...39,971,902
G
Cps1
carbamoyl-phosphate synthase 1
ISO
protein:increased expression:liver (rat)
RGD
PMID:20347174
RGD:4144089
NCBI chrNW_004955457:4,848,116...4,961,384
Ensembl chrNW_004955457:4,844,152...4,961,246
G
Creb1
cAMP responsive element binding protein 1
ISO
RGD
PMID:14614508
RGD:734818
NCBI chrNW_004955457:7,424,403...7,490,630
Ensembl chrNW_004955457:7,431,736...7,491,149
G
Ctsb
cathepsin B
ISO
mRNA, protein:increased expression, increased activity:liver, cytosol (rat)
RGD
PMID:18452148
RGD:2315513
NCBI chrNW_004955403:53,086,236...53,100,217
Ensembl chrNW_004955403:53,085,574...53,093,809
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
mRNA,protein:increased expression:liver,serum
RGD
PMID:25048951
RGD:27095890
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
G
Cxcl8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23348005
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
G
Ddit3
DNA damage inducible transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27664470
NCBI chrNW_004955458:5,232,979...5,238,513
Ensembl chrNW_004955458:5,232,979...5,238,513
G
Dgat2
diacylglycerol O-acyltransferase 2
treatment
ISO
RGD
PMID:17526931
RGD:10400884
NCBI chrNW_004955414:16,059,781...16,089,727
Ensembl chrNW_004955414:16,059,781...16,089,727
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
treatment
ISO
RGD
PMID:27813192
RGD:401842386
NCBI chrNW_004955424:210,867...279,267
Ensembl chrNW_004955424:226,038...280,593
G
Epas1
endothelial PAS domain protein 1
ISO
RGD
PMID:14608355
RGD:734934
NCBI chrNW_004955441:13,244,626...13,328,220
Ensembl chrNW_004955441:13,244,626...13,328,369
G
Ern1
endoplasmic reticulum to nucleus signaling 1
treatment
ISO
RGD
PMID:27813192
RGD:401842386
NCBI chrNW_004955478:7,720,664...7,803,662
Ensembl chrNW_004955478:7,751,830...7,799,460
G
F2
coagulation factor II, thrombin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008134
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
G
F2r
coagulation factor II thrombin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008134 PMID:21907177 PMID:22841818
NCBI chrNW_004955425:24,144,905...24,164,498
G
Fgf21
fibroblast growth factor 21
severity
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:24184811 PMID:32195457
RGD:25330354
NCBI chrNW_004955559:1,818,400...1,821,423
Ensembl chrNW_004955559:1,817,110...1,820,417
G
Fgfr1
fibroblast growth factor receptor 1
severity
ISO
RGD
PMID:32195457
RGD:25330354
NCBI chrNW_004955463:14,013,247...14,064,354
Ensembl chrNW_004955463:14,013,247...14,064,111
G
Fis1
fission, mitochondrial 1
ISO
protein:increased expression:liver (rat)
RGD
PMID:24663492
RGD:12453042
NCBI chrNW_004955456:16,057,158...16,060,623
Ensembl chrNW_004955456:16,038,221...16,060,623
G
Foxa1
forkhead box A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24469900
NCBI chrNW_004955409:23,598,127...23,599,827
Ensembl chrNW_004955409:23,598,127...23,599,461
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:29534506
RGD:14695544
NCBI chrNW_004955451:16,672,512...16,680,001
Ensembl chrNW_004955451:16,672,979...16,680,001
G
Gck
glucokinase
ISO
associated with Hyperglycemia
RGD
PMID:22925001
RGD:7488945
NCBI chrNW_004955456:7,784,269...7,838,260
Ensembl chrNW_004955456:7,783,760...7,842,129
G
Ggt1
gamma-glutamyltransferase 1
disease_progression
ISO
RGD
PMID:19670414
RGD:14747016
NCBI chrNW_004955455:8,082,578...8,099,523
G
Gpd1l
glycerol-3-phosphate dehydrogenase 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955430:23,481,957...23,536,407
Ensembl chrNW_004955430:23,481,957...23,539,495
G
Gpt
glutamic--pyruvic transaminase
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19481104 PMID:30185098
RGD:14975167
NCBI chrNW_004955454:3,127,997...3,132,459
Ensembl chrNW_004955454:3,127,997...3,132,459
G
Gpt2
glutamic--pyruvic transaminase 2
ISO
mRNA:increased expression:liver
RGD
PMID:15122758
RGD:14975241
NCBI chrNW_004955474:8,248,622...8,285,449
Ensembl chrNW_004955474:8,250,759...8,285,227
G
Gpx1
glutathione peroxidase 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10860543 PMID:30298849
RGD:401960083
NCBI chrNW_004955532:1,298,336...1,298,830
G
Gpx4
glutathione peroxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26042203
NCBI chrNW_004955495:6,767,969...6,772,256
Ensembl chrNW_004955495:6,767,975...6,772,178
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
DNA:point mutations: ;1132C>T,1528G>C;LCHAD deficiency,OMIM:609015
RGD
PMID:7846063
RGD:1599882
NCBI chrNW_004955469:8,183,945...8,233,869
Ensembl chrNW_004955469:8,183,945...8,233,869
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17116638
NCBI chrNW_004955469:8,233,980...8,272,149
Ensembl chrNW_004955469:8,233,980...8,274,450
G
Has3
hyaluronan synthase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27042213
NCBI chrNW_004955484:7,542,286...7,570,108
Ensembl chrNW_004955484:7,542,286...7,570,684
G
Hfe
homeostatic iron regulator
no_association
ISO
Non-alcoholic steatohepatitis (NASH)
RGD
PMID:12105842
RGD:1601460
NCBI chrNW_004955483:933,269...941,070
Ensembl chrNW_004955483:932,352...941,143
G
Hhex
hematopoietically expressed homeobox
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24469900
NCBI chrNW_004955425:737,506...742,775
Ensembl chrNW_004955425:735,378...742,775
G
Hm13
histocompatibility minor 13
ISO
associated with hepatitis
RGD
PMID:27142248
RGD:40924634
NCBI chrNW_004955422:29,365,722...29,408,788
Ensembl chrNW_004955422:29,362,724...29,408,840
G
Hsd17b13
hydroxysteroid 17-beta dehydrogenase 13
ISO
ClinVar Annotator: match by term: HSD17B13 POLYMORPHISM
ClinVar
PMID:29562163 PMID:34930143
NCBI chrNW_004955474:2,532,213...2,554,324
Ensembl chrNW_004955474:2,532,213...2,555,260
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
ISO
associated with Diabetes Mellitus, Experimental;mRNA:increased expression:liver:
RGD
PMID:23647685 PMID:27813192
RGD:11354957 RGD:401842386
NCBI chrNW_004955419:3,055,420...3,060,208
Ensembl chrNW_004955419:3,055,420...3,062,131
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
associated with morbid obesity;mRNA:decreased expression:liver
RGD
PMID:33081272
RGD:401900305
NCBI chrNW_004955431:583,165...646,991
Ensembl chrNW_004955431:580,713...647,345
G
Htr2b
5-hydroxytryptamine receptor 2B
ISO
associated with morbid obesity;mRNA:decreased expression:liver
RGD
PMID:33081272
RGD:401900305
NCBI chrNW_004955453:4,352,278...4,367,807
Ensembl chrNW_004955453:4,351,668...4,367,807
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
OMIM:228100
MouseDO
NCBI chrNW_004955580:1,053,823...1,069,802
Ensembl chrNW_004955580:1,053,823...1,069,802
G
Il10
interleukin 10
ISO
associated with Diabetes Mellitus
RGD
PMID:18267346
RGD:2308948
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
RGD
PMID:18802068
RGD:4145478
NCBI chrNW_004955490:708,144...758,195
Ensembl chrNW_004955490:709,446...758,272
G
Il18
interleukin 18
ISO
RGD
PMID:19084941
RGD:4889416
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:serum mRNA:decreased expression:stomach (human)
RGD
PMID:17436085 PMID:24716593
RGD:1626661 RGD:405650681
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Il6
interleukin 6
ISO
associated with Diabetes Mellitus; protein:increased expression:extracellular space (mouse) associated with Diabetes Mellitus, Experimental; mRNA, protein:increased expression:liver, extracellular space (rat)
RGD
PMID:19076162 PMID:19205029
RGD:2307258 RGD:2307264
NCBI chrNW_004955410:25,079,835...25,084,390
G
Ins
insulin
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9048448 PMID:18713300
RGD:2311137
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
G
Insig1
insulin induced gene 1
severity
ISO
associated with Obesity;mRNA:increased expression:liver
RGD
PMID:15096598
RGD:2308857
NCBI chrNW_004955491:8,333,624...8,344,658
Ensembl chrNW_004955491:8,335,359...8,344,658
G
Insig2
insulin induced gene 2
severity
ISO
associated with Obesity
RGD
PMID:15096598
RGD:2308857
NCBI chrNW_004955459:11,571,582...11,596,069
Ensembl chrNW_004955459:11,571,145...11,592,146
G
Insr
insulin receptor
treatment
ISO
associated with obesity;human gene in mouse model protein:decreased phosphorylation: liver (rat)
RGD
PMID:22546076 PMID:25160038 PMID:30642871
RGD:14700926 RGD:14700935 RGD:14701028
NCBI chrNW_004955563:1,867,400...2,011,845
Ensembl chrNW_004955563:1,867,400...2,009,149
G
Jak2
Janus kinase 2
ISO
RGD
PMID:22275361
RGD:6483019
NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208
G
Keap1
kelch like ECH associated protein 1
ISO
RGD
PMID:22367278
RGD:6893372
NCBI chrNW_004955495:1,704,695...1,711,339
Ensembl chrNW_004955495:1,704,695...1,711,290
G
Ldlr
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism OMIM:228100
RGD CTD MouseDO
PMID:25554529 PMID:29459263 PMID:36108984
RGD:13703129
NCBI chrNW_004955495:2,114,702...2,135,584
Ensembl chrNW_004955495:2,114,434...2,138,056
G
Lep
leptin
severity
ISO
associated with morbid obesity;protein:decreased exprssion:serum (human) CTD Direct Evidence: marker/mechanism OMIM:228100
RGD CTD MouseDO
PMID:12661780 PMID:19716478 PMID:24525044 PMID:25554529 PMID:27071101 PMID:27712037 PMID:28281237 More...
RGD:21201250
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
G
Lepr
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25367288 PMID:29743445
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
G
Lgals3
galectin 3
ISO
OMIM:228100
MouseDO
NCBI chrNW_004955409:8,448,120...8,452,437
Ensembl chrNW_004955409:8,447,774...8,452,438
G
LOC102009223
cytochrome P450 1B1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27036855
NCBI chrNW_004955441:5,803,397...5,812,131
Ensembl chrNW_004955441:5,803,032...5,812,131
G
LOC102011841
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:31175967
RGD:25671414
NCBI chrNW_004955458:5,472,404...5,477,001
Ensembl chrNW_004955458:5,472,404...5,477,001
G
LOC102022645
25-hydroxycholesterol 7-alpha-hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23391614
NCBI chrNW_004955444:14,274,818...14,446,068
Ensembl chrNW_004955444:14,275,345...14,444,426
G
LOC102023780
aromatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11929713
NCBI chrNW_004955409:3,198,622...3,313,072
Ensembl chrNW_004955409:3,266,233...3,313,142
G
LOC102023786
cytochrome c, somatic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10860543
NCBI chrNW_004955410:27,086,405...27,089,255
Ensembl chrNW_004955410:27,086,405...27,089,255
G
LOC102026028
cytochrome P450 2E1
ISO
DNA:polymorphism:5' utr:reduced frequency of homozygotic C1 RFLP (PstI+, RsaI-) and increased frequency of C2 RFLP (PstI-,RsaI+) in Chinese patients protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:14606109 PMID:18952117 PMID:19404342
RGD:1626302 RGD:4892244
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
G
LOC102027549
serotransferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008134 PMID:21907177
NCBI chrNW_004955501:4,801,710...4,832,025
Ensembl chrNW_004955501:4,801,885...4,831,910
G
Lrp6
LDL receptor related protein 6
ISO
OMIM:228100
MouseDO
NCBI chrNW_004955413:9,080,901...9,237,644
Ensembl chrNW_004955413:9,080,914...9,237,650
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
ameliorates
ISO
RGD
PMID:26560698
RGD:11342977
NCBI chrNW_004955429:21,717,153...21,739,349
Ensembl chrNW_004955429:21,716,958...21,741,585
G
Mapk8
mitogen-activated protein kinase 8
ISO
RGD
PMID:21540183
RGD:9585751
NCBI chrNW_004955556:1,593,552...1,705,543
Ensembl chrNW_004955556:1,593,494...1,665,784
G
Mat1a
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12060674
NCBI chrNW_004955510:283,860...300,991
Ensembl chrNW_004955510:281,331...300,985
G
Mc4r
melanocortin 4 receptor
ISO
OMIM:228100
MouseDO
NCBI chrNW_004955402:44,453,973...44,456,689
Ensembl chrNW_004955402:44,455,294...44,456,292
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32045588
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
G
Mfn2
mitofusin 2
ISO
protein:decreased expression:liver (rat)
RGD
PMID:24663492
RGD:12453042
NCBI chrNW_004955486:1,937,873...1,962,577
Ensembl chrNW_004955486:1,937,802...1,962,772
G
Mthfr
methylenetetrahydrofolate reductase
ISO
associated with Hepatitis C, Chronic; DNA:transition:cds:g.677C>T (human)
RGD
PMID:15834927
RGD:1580580
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
G
Mttp
microsomal triglyceride transfer protein
ISO
associated with Hepatitis C;mRNA:decreased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16697730 PMID:17303181
RGD:1625483
NCBI chrNW_004955496:7,963,323...8,022,393
Ensembl chrNW_004955496:7,963,262...8,009,838
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24210820
NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982
G
Neil1
nei like DNA glycosylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16446448 PMID:21285402
NCBI chrNW_004955450:2,883,344...2,889,593
Ensembl chrNW_004955450:2,883,560...2,887,736
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22367278 PMID:28555106
RGD:6893372
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
G
Nfkb1
nuclear factor kappa B subunit 1
ISO
RGD
PMID:21643627
RGD:5135028
NCBI chrNW_004955496:5,842,734...5,950,995
Ensembl chrNW_004955496:5,842,600...5,927,885
G
Nox4
NADPH oxidase 4
treatment
ISO
RGD
PMID:30298849
RGD:401960083
NCBI chrNW_004955414:4,062,337...4,220,032
Ensembl chrNW_004955414:4,062,081...4,212,746
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
protein:increased activity:liver
RGD
PMID:17721935
RGD:5133249
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
G
Nr0b2
nuclear receptor subfamily 0 group B member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27664470
NCBI chrNW_004955452:6,251,047...6,253,541
Ensembl chrNW_004955452:6,250,889...6,254,541
G
Nr1d1
nuclear receptor subfamily 1 group D member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27664470
NCBI chrNW_004955451:14,743,763...14,750,903
Ensembl chrNW_004955451:14,742,735...14,750,999
G
Nr1h3
nuclear receptor subfamily 1 group H member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23651738
NCBI chrNW_004955422:940,310...954,170
Ensembl chrNW_004955422:940,310...949,049
G
Nr1h4
nuclear receptor subfamily 1 group H member 4
severity treatment
ISO
knockout eliminates treatment effectiveness CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12971955 PMID:23104131 PMID:29142166
RGD:14696795 RGD:15045573
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
G
Nr1i2
nuclear receptor subfamily 1 group I member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25182422
NCBI chrNW_004955427:19,459,936...19,487,276
Ensembl chrNW_004955427:19,459,936...19,487,276
G
Nr3c2
nuclear receptor subfamily 3 group C member 2
treatment
ISO
RGD
PMID:30298849
RGD:401960083
NCBI chrNW_004955471:3,059,210...3,397,894
Ensembl chrNW_004955471:3,061,735...3,395,520
G
Nrep
neuronal regeneration related protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955418:3,435,784...3,464,667
Ensembl chrNW_004955418:3,436,731...3,464,667
G
Nus1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33812996
NCBI chrNW_004955436:825,387...850,558
Ensembl chrNW_004955436:825,387...850,558
G
Opa1
OPA1 mitochondrial dynamin like GTPase
ISO
ClinVar Annotator: match by term: Hepatic steatosis
ClinVar
PMID:12036970 PMID:19303950 PMID:20157015 PMID:22857269 PMID:23388408 PMID:25741868 PMID:26467025 PMID:27165006 PMID:27890673 PMID:28492532 PMID:31521625 PMID:32420686 PMID:37196654 More...
NCBI chrNW_004955420:14,927,490...15,007,082
Ensembl chrNW_004955420:14,923,575...15,007,081
G
Otc
ornithine transcarbamylase
ISO
protein:increased expression:serum (rat)
RGD
PMID:18823438
RGD:4144061
NCBI chrNW_004955601:481,524...543,176
Ensembl chrNW_004955601:481,480...543,176
G
Pex5
peroxisomal biogenesis factor 5
ISO
RGD
PMID:21756965
RGD:25440484
NCBI chrNW_004955413:4,736,189...4,755,559
Ensembl chrNW_004955413:4,736,189...4,755,766
G
Plau
plasminogen activator, urokinase
ISO
OMIM:228100
MouseDO
NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209
G
Plin2
perilipin 2
ISO
associated with Obesity CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16439473 PMID:17484887
RGD:1625752
NCBI chrNW_004955434:21,573,860...21,580,990
Ensembl chrNW_004955434:21,574,292...21,580,988
G
Pnpla3
patatin like phospholipase domain containing 3
severity
ISO
CTD Direct Evidence: marker/mechanism associated with Hepatitis C, Chronic;DNA:SNP: :rs738409 (p.I148M) (human) associated with Hepatitis B, Chronic;DNA:SNP: :rs738409 (p.I148M) (human) associated with Wilson disease;DNA:SNP: :rs738409 (p.I148M) (human)
CTD RGD
PMID:21319195 PMID:23564580 PMID:25284145 PMID:25678388
RGD:11055420 RGD:14981583 RGD:14981585 RGD:14981590
NCBI chrNW_004955413:28,879,646...28,896,224
Ensembl chrNW_004955413:28,879,748...28,893,938
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:167377
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26945512
NCBI chrNW_004955432:11,893,473...11,923,035
Ensembl chrNW_004955432:11,893,473...11,923,339
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
associated with Hepatitis C, Chronic;mRNA:decreased expression:liver (human) associated with Diabetes Mellitus (CTD:0000249); in high fat-fed foz/foz obese/diabetic mice CTD Direct Evidence: therapeutic
RGD CTD
PMID:16393287 PMID:19124612 PMID:21929649
RGD:15042851 RGD:5509939
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
G
Ppard
peroxisome proliferator activated receptor delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23851158
NCBI chrNW_004955437:3,285,281...3,354,099
Ensembl chrNW_004955437:3,288,830...3,357,048
G
Pparg
peroxisome proliferator activated receptor gamma
treatment
ISO
RGD
PMID:15112352 PMID:30298849
RGD:1580685 RGD:401960083
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
ISO
protein:decreased methylation:liver (rat)
RGD
PMID:22521344 PMID:23174781 PMID:23274094
RGD:7241844 RGD:7242012 RGD:7242179
NCBI chrNW_004955480:543,397...1,188,376
Ensembl chrNW_004955480:1,078,322...1,188,435
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
ISO
RGD
PMID:19162361
RGD:6484544
NCBI chrNW_004955426:25,079,718...25,102,090
Ensembl chrNW_004955426:25,079,718...25,102,090
G
Prkcd
protein kinase C delta
ISO
RGD
PMID:17596878
RGD:1642523
NCBI chrNW_004955430:3,125,066...3,151,857
Ensembl chrNW_004955430:3,124,738...3,153,274
G
Prmt7
protein arginine methyltransferase 7
ISO
ClinVar Annotator: match by term: Hepatic steatosis
ClinVar
PMID:25741868 PMID:26437029 PMID:27718516 PMID:28492532 PMID:28902392
NCBI chrNW_004955484:8,299,427...8,352,465
Ensembl chrNW_004955484:8,299,427...8,340,287
G
Psma5
proteasome 20S subunit alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955435:12,823,137...12,845,631
Ensembl chrNW_004955435:12,822,707...12,846,296
G
Pten
phosphatase and tensin homolog
ISO
protein:decreased expression:liver OMIM:228100 CTD Direct Evidence: marker/mechanism
RGD MouseDO CTD
PMID:15199412 PMID:18166358 PMID:27022031
RGD:1302555 RGD:2292522
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
mRNA,protein:increased expression:liver
RGD
PMID:21643627
RGD:5135028
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
G
Ptma
prothymosin alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15885234
NCBI chrNW_004955453:4,036,503...4,037,788
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
RGD
PMID:21643627
RGD:5135028
NCBI chrNW_004955422:19,602,930...19,612,263
Ensembl chrNW_004955422:19,603,345...19,611,516
G
Ripk3
receptor interacting serine/threonine kinase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26769846
NCBI chrNW_004955409:35,961,604...35,965,477
Ensembl chrNW_004955409:35,937,880...35,965,712
G
Serpina6
serpin family A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955438:16,356,600...16,380,861
Ensembl chrNW_004955438:16,356,540...16,380,872
G
Serpine1
serpin family E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18641190 PMID:29684222
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
G
Shc1
SHC adaptor protein 1
ISO
associated with Obesity
RGD
PMID:17596878
RGD:1642523
NCBI chrNW_004955545:1,468,391...1,479,209
Ensembl chrNW_004955545:1,468,391...1,476,814
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic OMIM:228100 associated with Obesity
CTD MouseDO RGD
PMID:21321189 PMID:21540183 PMID:23834033 PMID:24184811 PMID:24210820 PMID:24442997 More...
RGD:9585751
NCBI chrNW_004955425:20,280,725...20,307,663
Ensembl chrNW_004955425:20,279,963...20,307,663
G
Sirt6
sirtuin 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28536482
NCBI chrNW_004955495:4,641,883...4,650,518
Ensembl chrNW_004955495:4,644,023...4,650,083
G
Sirt7
sirtuin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24210820
NCBI chrNW_004955506:1,252,271...1,258,728
Ensembl chrNW_004955506:1,252,274...1,258,728
G
Slc13a5
solute carrier family 13 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26303333
NCBI chrNW_004955467:12,181,555...12,217,280
Ensembl chrNW_004955467:12,182,766...12,216,842
G
Slc22a8
solute carrier family 22 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955599:284,038...299,603
Ensembl chrNW_004955599:283,929...300,796
G
Slc27a4
solute carrier family 27 member 4
ISO
mRNA, protein:increased expression
RGD
PMID:16248953
RGD:1625640
NCBI chrNW_004955570:853,856...866,383
Ensembl chrNW_004955570:853,849...866,383
G
Slc2a2
solute carrier family 2 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12048068
NCBI chrNW_004955420:1,101,769...1,129,672
Ensembl chrNW_004955420:1,101,769...1,129,715
G
Slco1a2
solute carrier organic anion transporter family member 1A2
ISO
RGD
PMID:16139386
RGD:1598602
NCBI chrNW_004955413:16,821,808...16,910,511
Ensembl chrNW_004955413:16,821,791...16,912,903
G
Socs1
suppressor of cytokine signaling 1
ISO
associated with Obesity
RGD
PMID:15240880
RGD:1625677
NCBI chrNW_004955442:7,321,337...7,323,109
Ensembl chrNW_004955442:7,321,337...7,323,109
G
Socs3
suppressor of cytokine signaling 3
ISO
associated with Obesity
RGD
PMID:15240880
RGD:1625677
NCBI chrNW_004955506:4,222,455...4,225,563
Ensembl chrNW_004955506:4,222,455...4,225,563
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27349771
NCBI chrNW_004955407:31,261,451...31,267,657
Ensembl chrNW_004955407:31,263,863...31,267,727
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10860543
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
G
Srebf1
sterol regulatory element binding transcription factor 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24469900 PMID:27813192
RGD:401842386
NCBI chrNW_004955577:171,425...183,669
Ensembl chrNW_004955577:171,425...186,046
G
Stat4
signal transducer and activator of transcription 4
ISO
RGD
PMID:16799967
RGD:25671424
NCBI chrNW_004955403:8,061,471...8,144,252
Ensembl chrNW_004955403:8,061,471...8,144,276
G
Sts
steroid sulfatase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24497646
NCBI chrNW_004955499:5,180,451...5,347,862
Ensembl chrNW_004955499:5,180,214...5,345,221
G
Suox
sulfite oxidase
ISO
protein:decreased expression:liver
RGD
PMID:15144217
RGD:1600114
NCBI chrNW_004955458:3,584,390...3,589,764
Ensembl chrNW_004955458:3,585,482...3,590,559
G
Tlr4
toll like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18641190 PMID:27022031
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23348005
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver
CTD RGD
PMID:10860543 PMID:21114362
RGD:7204423
NCBI chrNW_004955414:17,592,914...17,596,477
Ensembl chrNW_004955414:17,592,914...17,596,477
G
Vdr
vitamin D receptor
ISO
RGD
PMID:30905785
RGD:14402029
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
G
Xbp1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097666
NCBI chrNW_004955455:3,037,885...3,041,827
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:plasma
RGD
PMID:16115302
RGD:5686674
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
G
Adipor2
adiponectin receptor 2
treatment
ISO
RGD
PMID:18755807 PMID:22013387 PMID:26115886 PMID:27220557
RGD:25330099 RGD:25440493 RGD:25824939 RGD:25824943
NCBI chrNW_004955454:4,243,898...4,327,255
Ensembl chrNW_004955454:4,243,898...4,327,308
G
Adra2a
adrenoceptor alpha 2A
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chrNW_004955485:384,405...387,332
Ensembl chrNW_004955485:385,800...387,240
G
Aldh2
aldehyde dehydrogenase 2 family member
susceptibility severity treatment
ISO
DNA:missense mutation:cds:p.E504K (human) human transgene in mouse model protein:altered processing:liver (mouse)
RGD
PMID:17058263 PMID:25457208 PMID:29063269 PMID:29156373
RGD:14696776 RGD:15036805 RGD:15036811 RGD:1599041
NCBI chrNW_004955482:8,352,569...8,383,097
Ensembl chrNW_004955482:8,352,569...8,384,899
G
Arrb2
arrestin beta 2
ameliorates
ISO
protein:increased expression:hepatocyte
RGD
PMID:33871024
RGD:401938594
NCBI chrNW_004955467:10,109,985...10,118,687
Ensembl chrNW_004955467:10,110,003...10,123,022
G
Birc3
baculoviral IAP repeat containing 3
ISO
protein:increased expression:liver (human)
RGD
PMID:29307797
RGD:153297819
NCBI chrNW_004955412:5,624,865...5,643,520
Ensembl chrNW_004955412:5,628,973...5,643,410
G
C1qc
complement C1q C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35789393
NCBI chrNW_004955452:2,759,079...2,762,522
Ensembl chrNW_004955452:2,758,821...2,762,522
G
Ccr2
C-C motif chemokine receptor 2
treatment
ISO
RGD
PMID:25557254
RGD:14995489
NCBI chrNW_004955420:25,641,184...25,664,413
G
Cd36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:24280415
RGD:11041117
NCBI chrNW_004955410:5,003,720...5,120,903
Ensembl chrNW_004955410:5,003,668...5,075,313
G
Ctsb
cathepsin B
ISO
protein:increased activity:liver, cytosol (rat)
RGD
PMID:17850215
RGD:2315516
NCBI chrNW_004955403:53,086,236...53,100,217
Ensembl chrNW_004955403:53,085,574...53,093,809
G
Dnmt1
DNA methyltransferase 1
ISO
RGD
PMID:22905112
RGD:9588654
NCBI chrNW_004955495:1,465,529...1,505,379
Ensembl chrNW_004955495:1,465,480...1,505,462
G
Fkbp5
FKBP prolyl isomerase 5
ameliorates
ISO
mRNA,protein:incrased expression:liver (human)
RGD
PMID:33710653
RGD:401976495
NCBI chrNW_004955437:3,445,515...3,548,874
Ensembl chrNW_004955437:3,447,075...3,548,564
G
Foxo1
forkhead box O1
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chrNW_004955431:5,797,359...5,890,758
G
Hamp
hepcidin antimicrobial peptide
ISO
mRNA:decreased expression:liver
RGD
PMID:19253830
RGD:11041633
NCBI chrNW_004955468:4,576,080...4,577,591
Ensembl chrNW_004955468:4,575,510...4,577,649
G
Ldlr
low density lipoprotein receptor
ISO
protein:decreased expression: liver (rat)
RGD
PMID:20028367
RGD:21410185
NCBI chrNW_004955495:2,114,702...2,135,584
Ensembl chrNW_004955495:2,114,434...2,138,056
G
LOC102026028
cytochrome P450 2E1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:24064383 PMID:25583360 PMID:26428356
RGD:14700870 RGD:14700884
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
G
Nlrc5
NLR family CARD domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36708882
NCBI chrNW_004955433:14,670,273...14,752,739
Ensembl chrNW_004955433:14,670,207...14,751,782
G
Nr1h3
nuclear receptor subfamily 1 group H member 3
treatment
ISO
RGD
PMID:26256083
RGD:11522097
NCBI chrNW_004955422:940,310...954,170
Ensembl chrNW_004955422:940,310...949,049
G
Pemt
phosphatidylethanolamine N-methyltransferase
ISO
RGD
PMID:17156888
RGD:1642369
NCBI chrNW_004955577:365,031...443,138
Ensembl chrNW_004955577:367,288...443,138
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18703563
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
G
Serpine1
serpin family E member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:25561792
RGD:11075083
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
G
Serpinf1
serpin family F member 1
ISO
protein:decreased expression:liver
RGD
PMID:18996124
RGD:2312349
NCBI chrNW_004955481:1,414,930...1,426,436
Ensembl chrNW_004955481:1,414,930...1,426,241
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19951287
NCBI chrNW_004955407:31,261,451...31,267,657
Ensembl chrNW_004955407:31,263,863...31,267,727
G
Sod2
superoxide dismutase 2
ISO
RGD
PMID:11477087
RGD:1625694
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
G
Stat4
signal transducer and activator of transcription 4
ISO
RGD
PMID:18296740
RGD:7207884
NCBI chrNW_004955403:8,061,471...8,144,252
Ensembl chrNW_004955403:8,061,471...8,144,276
G
Tead1
TEA domain transcription factor 1
ameliorates
ISO
RGD
PMID:33710653
RGD:401976495
NCBI chrNW_004955414:28,166,562...28,341,275
Ensembl chrNW_004955414:28,175,543...28,333,856
G
Tlr4
toll like receptor 4
severity
ISO
RGD
PMID:21463341 PMID:29884546
RGD:14697697 RGD:14700554
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
G
Tnf
tumor necrosis factor
susceptibility treatment
ISO
DNA:SNP:promoter:-238G>A (human)
RGD
PMID:9214463 PMID:20143470
RGD:14995434 RGD:38508901
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Ubd
ubiquitin D
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chrNW_004955583:29,438...29,873
Ensembl chrNW_004955583:29,438...31,555
G
Adk
adenosine kinase
ISO
RGD
PMID:11997462
RGD:1300259
NCBI chrNW_004955437:17,279,541...17,786,140
Ensembl chrNW_004955437:17,279,240...17,786,079
G
Abca1
ATP binding cassette subfamily A member 1
treatment
ISO
RGD
PMID:29505790
RGD:19165131
NCBI chrNW_004955419:21,553,863...21,681,626
Ensembl chrNW_004955419:21,553,835...21,681,619
G
Acaca
acetyl-CoA carboxylase alpha
treatment
ISO
RGD
PMID:28458350
RGD:401799674
NCBI chrNW_004955451:679,033...909,892
Ensembl chrNW_004955451:600,254...909,892
G
Acer3
alkaline ceramidase 3
disease_progression treatment
ISO
mRNA:increased expression:liver
RGD
PMID:31949129
RGD:35673324
NCBI chrNW_004955414:14,741,027...14,846,931
Ensembl chrNW_004955414:14,746,529...14,848,151
G
Acta2
actin alpha 2, smooth muscle
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:28100771
RGD:127285675
NCBI chrNW_004955425:4,023,001...4,039,980
Ensembl chrNW_004955425:4,026,430...4,040,747
G
Adipor2
adiponectin receptor 2
treatment susceptibility
ISO
mRNA:decreased expression:liver (rat) associated with obesity;protein:decreased expression:liver (mouse)
RGD
PMID:18666257 PMID:19763702 PMID:20606728 PMID:20965162 PMID:30131158
RGD:21076282 RGD:25330094 RGD:25330095 RGD:25440494 RGD:25824942
NCBI chrNW_004955454:4,243,898...4,327,255
Ensembl chrNW_004955454:4,243,898...4,327,308
G
Adra2a
adrenoceptor alpha 2A
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chrNW_004955485:384,405...387,332
Ensembl chrNW_004955485:385,800...387,240
G
Apoa1
apolipoprotein A1
treatment
ISO
mRNA, protein: increased expression:liver, serum (rat) human gene in mouse model
RGD
PMID:24793484 PMID:30187493
RGD:21408551 RGD:25671434
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
treatment
ISO
associated with type 2 diabetes mellitus;
RGD
PMID:29608898
RGD:153352320
NCBI chrNW_004955573:902,153...910,481
Ensembl chrNW_004955573:899,798...912,272
G
Birc3
baculoviral IAP repeat containing 3
ISO
protein:increased expression:liver (human)
RGD
PMID:29307797
RGD:153297819
NCBI chrNW_004955412:5,624,865...5,643,520
Ensembl chrNW_004955412:5,628,973...5,643,410
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:serum:
RGD
PMID:27639593
RGD:14995335
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
G
Cldn1
claudin 1
ISO
mRNA:increased expression:distal colon (rat)
RGD
PMID:31189495
RGD:26884351
NCBI chrNW_004955420:17,798,974...17,815,049
Ensembl chrNW_004955420:17,798,974...17,815,205
G
Col1a1
collagen type I alpha 1 chain
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
G
Cpt1a
carnitine palmitoyltransferase 1A
treatment
ISO
RGD
PMID:28458350
RGD:401799674
NCBI chrNW_004955422:17,105,887...17,159,696
Ensembl chrNW_004955422:17,109,256...17,159,838
G
Cxcl10
C-X-C motif chemokine ligand 10
severity
ISO
mRNA,protein:increased expression:liver,serum
RGD
PMID:25048951
RGD:27095890
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
G
Gpbar1
G protein-coupled bile acid receptor 1
treatment
ISO
mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:30038487
RGD:15092090
NCBI chrNW_004955453:15,109,711...15,112,438
Ensembl chrNW_004955453:15,109,711...15,112,438
G
Htr2b
5-hydroxytryptamine receptor 2B
ISO
associated with morbid obesity;mRNA:decreased expression:liver
RGD
PMID:33081272
RGD:401900305
NCBI chrNW_004955453:4,352,278...4,367,807
Ensembl chrNW_004955453:4,351,668...4,367,807
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ameliorates
ISO
RGD
PMID:28415887
RGD:14985253
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
G
Ifng
interferon gamma
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
G
Il10
interleukin 10
ISO
DNA:SNP:promoter:-1082A>G (rs1800896) (human)
RGD
PMID:28852433
RGD:14975143
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
G
Il1b
interleukin 1 beta
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Il6
interleukin 6
ameliorates
ISO
DNA:SNP:promoter:-174G>C (human)
RGD
PMID:28100771 PMID:28852433
RGD:127285675 RGD:14975143
NCBI chrNW_004955410:25,079,835...25,084,390
G
Jak2
Janus kinase 2
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208
G
Krt18
keratin 18
severity
ISO
protein:increased degradation:serum (human) associated with morbid obesity;protein:increased degradation:plasma (human) protein:altered degradation:liver, serum (rat) protein:increased expression:serum (human)
RGD MouseDO
PMID:18995215 PMID:19333204 PMID:19585618 PMID:21993925 PMID:24071521 PMID:24630506 More...
RGD:18337489 RGD:18337490 RGD:18337493 RGD:18337495 RGD:18337499 RGD:27226810
NCBI chrNW_004955458:227,017...230,752
Ensembl chrNW_004955458:226,805...232,728
G
Lepr
leptin receptor
susceptibility
ISO
DNA:SNPs: : (rs1137100, rs1137101) (human)
RGD
PMID:23278404
RGD:14696696
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
G
LOC102004889
sterol 26-hydroxylase, mitochondrial
ISO
mRNA:increased expression:liver (human)
RGD
PMID:28774887
RGD:15045601
NCBI chrNW_004955453:14,601,495...14,647,383
Ensembl chrNW_004955453:14,601,444...14,647,366
G
LOC102008593
cholesterol 7-alpha-monooxygenase
treatment
ISO
mRNA:increased expression:liver (human) mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:28774887 PMID:30038487
RGD:15045601 RGD:15092090
NCBI chrNW_004955454:17,035,105...17,078,854
Ensembl chrNW_004955454:17,036,204...17,042,756
G
Mc4r
melanocortin 4 receptor
ISO
MouseDO
NCBI chrNW_004955402:44,453,973...44,456,689
Ensembl chrNW_004955402:44,455,294...44,456,292
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
ISO
RGD
PMID:32015322
RGD:151356909
NCBI chrNW_004955413:238,043...243,317
G
Mlxipl
MLX interacting protein like
treatment
ISO
RGD
PMID:28458350
RGD:401799674
NCBI chrNW_004955456:14,096,530...14,116,687
Ensembl chrNW_004955456:14,096,531...14,117,269
G
Myd88
MYD88 innate immune signal transduction adaptor
treatment
ISO
RGD
PMID:25790822
RGD:150519907
NCBI chrNW_004955427:25,553,589...25,557,654
Ensembl chrNW_004955427:25,553,589...25,559,138
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:25385666
RGD:21201312
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
G
Nfkb1
nuclear factor kappa B subunit 1
treatment
ISO
mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:30038487
RGD:15092090
NCBI chrNW_004955496:5,842,734...5,950,995
Ensembl chrNW_004955496:5,842,600...5,927,885
G
Nox4
NADPH oxidase 4
susceptibility
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:20606728
RGD:21076282
NCBI chrNW_004955414:4,062,337...4,220,032
Ensembl chrNW_004955414:4,062,081...4,212,746
G
Nr1h4
nuclear receptor subfamily 1 group H member 4
treatment
ISO
mRNA, protein:altered expression:liver (rat) treatment with INT-767 mRNA:increased expression:liver (human)
RGD
PMID:28774887 PMID:30038487
RGD:15045601 RGD:15092090
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
G
Pck1
phosphoenolpyruvate carboxykinase 1
treatment
ISO
mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:30038487
RGD:15092090
NCBI chrNW_004955445:1,909,012...1,914,032
Ensembl chrNW_004955445:1,908,946...1,915,002
G
Ripk3
receptor interacting serine/threonine kinase 3
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21425308
RGD:127229938
NCBI chrNW_004955409:35,961,604...35,965,477
Ensembl chrNW_004955409:35,937,880...35,965,712
G
Serpinf1
serpin family F member 1
treatment
ISO
protein:increased expression:serum (human) human gene in a mouse model
RGD
PMID:26121037 PMID:28365916
RGD:27226700 RGD:27226705
NCBI chrNW_004955481:1,414,930...1,426,436
Ensembl chrNW_004955481:1,414,930...1,426,241
G
Smad4
SMAD family member 4
ISO
protein:increased expression:liver:
RGD
PMID:29696816
RGD:18937002
NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538
G
Sod1
superoxide dismutase 1
susceptibility
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:20606728
RGD:21076282
NCBI chrNW_004955407:31,261,451...31,267,657
Ensembl chrNW_004955407:31,263,863...31,267,727
G
Sod2
superoxide dismutase 2
susceptibility
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:20606728 PMID:24649902
RGD:21076282 RGD:26923960
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
G
Srebf1
sterol regulatory element binding transcription factor 1
treatment
ISO
mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:28458350 PMID:30038487
RGD:15092090 RGD:401799674
NCBI chrNW_004955577:171,425...183,669
Ensembl chrNW_004955577:171,425...186,046
G
Tlr2
toll like receptor 2
ISO
RGD
PMID:29482933
RGD:15090806
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
G
Tlr9
toll like receptor 9
disease_progression
ISO
mRNA, protein:increased expression:serum, liver (mouse)
RGD
PMID:24650018
RGD:18337469
NCBI chrNW_004955532:3,828,645...3,832,699
Ensembl chrNW_004955532:3,828,775...3,832,582
G
Tnf
tumor necrosis factor
susceptibility
ISO
mRNA:increased expression:liver (rat) mRNA:increased expression:liver (mouse)
RGD
PMID:20606728 PMID:28100771
RGD:127285675 RGD:21076282
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Txnip
thioredoxin interacting protein
ISO
RGD
PMID:29482933
RGD:15090806
NCBI chrNW_004955568:103,801...107,791
Ensembl chrNW_004955568:103,762...107,785
G
Ubd
ubiquitin D
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chrNW_004955583:29,438...29,873
Ensembl chrNW_004955583:29,438...31,555
G
Abcb1
ATP binding cassette subfamily B member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:22112382
RGD:11040992
NCBI chrNW_004955432:4,911,774...5,085,349
G
Abcc2
ATP binding cassette subfamily C member 2
severity
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs:exon:p.Glu1188Val(rs17222723),p.Tyr1515Cys(rs8187710)(human)
CTD RGD
PMID:18926681 PMID:29341352
RGD:14700775
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
G
Abcc3
ATP binding cassette subfamily C member 3
ISO
protein:increased expression:liver
RGD
PMID:22112382
RGD:11040992
NCBI chrNW_004955451:11,087,246...11,130,108
Ensembl chrNW_004955451:11,087,570...11,130,482
G
Abcg5
ATP binding cassette subfamily G member 5
disease_progression
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:23117815
RGD:15045604
NCBI chrNW_004955441:10,964,588...10,987,771
Ensembl chrNW_004955441:10,964,858...10,986,967
G
Abcg8
ATP binding cassette subfamily G member 8
disease_progression
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:23117815
RGD:15045604
NCBI chrNW_004955441:10,982,307...11,004,789
Ensembl chrNW_004955441:10,982,307...11,009,116
G
Acaca
acetyl-CoA carboxylase alpha
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004955451:679,033...909,892
Ensembl chrNW_004955451:600,254...909,892
G
Acacb
acetyl-CoA carboxylase beta
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004955455:10,282,308...10,427,439
Ensembl chrNW_004955455:10,308,192...10,426,076
G
Acadm
acyl-CoA dehydrogenase medium chain
treatment
ISO
RGD
PMID:23076603
RGD:10047124
NCBI chrNW_004955423:17,173,648...17,199,189
Ensembl chrNW_004955423:17,172,779...17,199,090
G
Acadvl
acyl-CoA dehydrogenase very long chain
treatment
ISO
RGD
PMID:22569299 PMID:23076603
RGD:10047121 RGD:10047124
NCBI chrNW_004955467:9,684,070...9,689,454
Ensembl chrNW_004955467:9,684,250...9,689,356
G
Aco1
aconitase 1
ISO
protein:increased activity:liver
RGD
PMID:23805238
RGD:11541090
NCBI chrNW_004955472:3,141,473...3,170,959
Ensembl chrNW_004955472:3,141,257...3,170,959
G
Actb
actin beta
ISO
protein:increased carbonylation:liver
RGD
PMID:25282656
RGD:11541097
NCBI chrNW_004955460:10,358,100...10,361,585
Ensembl chrNW_004955460:10,356,699...10,361,585
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO
mRNA, protein:increased expression, increased activity:liver, plasma (rat)
RGD
PMID:19652891
RGD:2315953
NCBI chrNW_004955513:2,761,386...2,786,447
Ensembl chrNW_004955513:2,764,186...2,786,187
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment susceptibility disease_progression
ISO
DNA:hypermethylation protein:decreased expression:serum DNA:SNPs:5'utr, :-11377C>G, +45T>G (rs266729, rs2241766) (human) CTD Direct Evidence: marker/mechanism associated with Obesity, Morbid; associated with type 2 diabetes mellitus;DNA:SNP:5' utr:-11377C>G (rs266729) (human) associated with obesity;protein:decreased expression:serum: mRNA, protein:decreased expression:liver
RGD CTD
PMID:15239085 PMID:18713296 PMID:19606393 PMID:20415685 PMID:21255792 PMID:22152320 PMID:22269154 PMID:26042596 PMID:27860427 More...
RGD:11076260 RGD:14401717 RGD:14401719 RGD:5685373 RGD:5686355 RGD:5686660 RGD:5686810 RGD:5686841
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
G
Adipor2
adiponectin receptor 2
susceptibility treatment severity
ISO
DNA:missense mutation:cds: (human) mRNA:increased expression:liver (rat) mRNA:increased expression:liver (human) mRNA, protein:decreased expression:serum, liver (mouse)
RGD
PMID:17006986 PMID:19422483 PMID:25345946 PMID:25536648 PMID:26770322 PMID:29569260 More...
RGD:1599139 RGD:24922200 RGD:24922201 RGD:25330097 RGD:25440492 RGD:25824941
NCBI chrNW_004955454:4,243,898...4,327,255
Ensembl chrNW_004955454:4,243,898...4,327,308
G
Adrb3
adrenoceptor beta 3
ISO
DNA:missense mutation:cds:p.W64R (rs4994) (human)
RGD
PMID:15318095
RGD:5684892
NCBI chrNW_004955463:13,663,064...13,665,553
G
Ahcy
adenosylhomocysteinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29127188
NCBI chrNW_004955422:26,992,295...27,013,100
Ensembl chrNW_004955422:26,992,295...27,013,100
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29416063
NCBI chrNW_004955410:20,428,531...20,459,482
Ensembl chrNW_004955410:20,428,546...20,456,836
G
Aldh1b1
aldehyde dehydrogenase 1 family member B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29718361
NCBI chrNW_004955419:28,155,174...28,159,752
Ensembl chrNW_004955419:28,155,174...28,159,752
G
Aldh1l2
aldehyde dehydrogenase 1 family member L2
ISO
OMIM:613282 | OMIM:613387
MouseDO
NCBI chrNW_004955405:39,387,949...39,437,282
Ensembl chrNW_004955405:39,387,527...39,437,322
G
Aldh2
aldehyde dehydrogenase 2 family member
susceptibility treatment
ISO
CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds: (rs671) (human)
CTD RGD
PMID:25392542 PMID:27214654 PMID:29718361 PMID:31026768
RGD:11536476 RGD:15036808 RGD:15042863
NCBI chrNW_004955482:8,352,569...8,383,097
Ensembl chrNW_004955482:8,352,569...8,384,899
G
Aldh4a1
aldehyde dehydrogenase 4 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29718361
NCBI chrNW_004955527:338,593...369,528
Ensembl chrNW_004955527:338,593...372,872
G
Alox15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:20967760
RGD:5509622
NCBI chrNW_004955467:10,032,792...10,039,789
G
Apoa1
apolipoprotein A1
treatment
ISO
RGD
PMID:26420354
RGD:25671437
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
G
Apoe
apolipoprotein E
ISO
RGD
PMID:21184788
RGD:6904141
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
Apoh
apolipoprotein H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35654975
NCBI chrNW_004955478:5,612,258...5,626,061
Ensembl chrNW_004955478:5,610,164...5,626,020
G
Atg7
autophagy related 7
ISO
ClinVar Annotator: match by term: NAFLD1
ClinVar
PMID:25741868 PMID:35405176
NCBI chrNW_004955429:14,076,976...14,301,034
Ensembl chrNW_004955429:14,076,960...14,304,236
G
Atp5f1a
ATP synthase F1 subunit alpha
ISO
RGD
PMID:25222487
RGD:13703054
NCBI chrNW_004955402:31,652,226...31,662,114
Ensembl chrNW_004955402:31,651,960...31,662,762
G
Atp5f1b
ATP synthase F1 subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25666834
NCBI chrNW_004955458:4,188,167...4,195,575
Ensembl chrNW_004955458:4,186,461...4,195,494
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
treatment
ISO
RGD
PMID:27982256
RGD:153352323
NCBI chrNW_004955573:902,153...910,481
Ensembl chrNW_004955573:899,798...912,272
G
B3gat1
beta-1,3-glucuronyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24211274
NCBI chrNW_004955412:35,294,434...35,321,873
Ensembl chrNW_004955412:35,294,434...35,321,851
G
C1qc
complement C1q C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35789393
NCBI chrNW_004955452:2,759,079...2,762,522
Ensembl chrNW_004955452:2,758,821...2,762,522
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29718361
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
G
Ccl5
C-C motif chemokine ligand 5
disease_progression treatment
ISO
RGD
PMID:27639593
RGD:14995335
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
G
Ccr2
C-C motif chemokine receptor 2
susceptibility
ISO
DNA:polymorphism: :190A>G(human)
RGD
PMID:26591766
RGD:14995492
NCBI chrNW_004955420:25,641,184...25,664,413
G
Cd14
CD14 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20353583
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
G
Cd36
CD36 molecule (CD36 blood group)
ISO
mRNA:increased expression:liver
RGD
PMID:21216282 PMID:24280415
RGD:11041117 RGD:6893543
NCBI chrNW_004955410:5,003,720...5,120,903
Ensembl chrNW_004955410:5,003,668...5,075,313
G
Cobll1
cordon-bleu WH2 repeat protein like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35654975
NCBI chrNW_004955449:9,340,716...9,400,049
Ensembl chrNW_004955449:9,340,716...9,404,308
G
Col1a1
collagen type I alpha 1 chain
treatment
ISO
RGD
PMID:17241878 PMID:23703580
RGD:2308807 RGD:8552713
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
G
Cpt1a
carnitine palmitoyltransferase 1A
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:29289645 PMID:31211621
RGD:14747028
NCBI chrNW_004955422:17,105,887...17,159,696
Ensembl chrNW_004955422:17,109,256...17,159,838
G
Csf2
colony stimulating factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21664615
NCBI chrNW_004955408:3,452,009...3,454,255
Ensembl chrNW_004955408:3,451,965...3,454,312
G
Cxcl10
C-X-C motif chemokine ligand 10
treatment
ISO
RGD
PMID:28824718
RGD:27095887
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
G
Dgat2
diacylglycerol O-acyltransferase 2
treatment
ISO
RGD
PMID:17618857 PMID:24166662 PMID:26394137
RGD:10400900 RGD:10401056 RGD:329955565
NCBI chrNW_004955414:16,059,781...16,089,727
Ensembl chrNW_004955414:16,059,781...16,089,727
G
Ech1
enoyl-CoA hydratase 1
treatment
ISO
RGD
PMID:31961704
RGD:21408561
NCBI chrNW_004955468:686,171...692,737
G
Eif2ak1
eukaryotic translation initiation factor 2 alpha kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29289645
NCBI chrNW_004955460:13,723,674...13,754,545
Ensembl chrNW_004955460:13,723,777...13,754,150
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
RGD
PMID:24351808
RGD:9588320
NCBI chrNW_004955491:4,215,353...4,292,229
Ensembl chrNW_004955491:4,215,298...4,292,235
G
F2
coagulation factor II, thrombin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22841818
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23127599
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
G
Fasn
fatty acid synthase
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004955506:1,063,002...1,079,939
Ensembl chrNW_004955506:1,063,002...1,079,939
G
Fgf21
fibroblast growth factor 21
severity
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:26797127 PMID:29289645 PMID:32195457
RGD:25330354
NCBI chrNW_004955559:1,818,400...1,821,423
Ensembl chrNW_004955559:1,817,110...1,820,417
G
Fgfr1
fibroblast growth factor receptor 1
severity
ISO
RGD
PMID:32195457
RGD:25330354
NCBI chrNW_004955463:14,013,247...14,064,354
Ensembl chrNW_004955463:14,013,247...14,064,111
G
Foxo1
forkhead box O1
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:30186875
RGD:14401598
NCBI chrNW_004955431:5,797,359...5,890,758
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver
CTD RGD
PMID:23329013 PMID:35654975
RGD:329951008
NCBI chrNW_004955433:11,424,069...11,834,955
Ensembl chrNW_004955433:11,424,176...11,813,771
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
treatment
ISO
associated with type 2 diabetes mellitus
RGD
PMID:27840945 PMID:30100243
RGD:14695535 RGD:14695545
NCBI chrNW_004955451:16,672,512...16,680,001
Ensembl chrNW_004955451:16,672,979...16,680,001
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:20211032
RGD:10449177
NCBI chrNW_004955580:1,045,294...1,058,129
Ensembl chrNW_004955580:1,045,294...1,057,083
G
Gnmt
glycine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31086990
NCBI chrNW_004955437:8,944,288...8,946,642
Ensembl chrNW_004955437:8,944,047...8,946,642
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004955431:17,291,890...17,363,611
Ensembl chrNW_004955431:17,291,270...17,363,714
G
Gpt
glutamic--pyruvic transaminase
severity
ISO
protein:increased activity:plasma CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22922605 PMID:24768200 PMID:35654975
RGD:14975160 RGD:14975251
NCBI chrNW_004955454:3,127,997...3,132,459
Ensembl chrNW_004955454:3,127,997...3,132,459
G
Gpt2
glutamic--pyruvic transaminase 2
ISO
protein:increased activity:plasma
RGD
PMID:22922605
RGD:14975251
NCBI chrNW_004955474:8,248,622...8,285,449
Ensembl chrNW_004955474:8,250,759...8,285,227
G
Gpx1
glutathione peroxidase 1
treatment
ISO
RGD
PMID:24597775
RGD:11352823
NCBI chrNW_004955532:1,298,336...1,298,830
G
Gsr
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24622831
RGD:10401873
NCBI chrNW_004955463:7,130,459...7,153,631
Ensembl chrNW_004955463:7,131,364...7,153,583
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23643483
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
protein:decreased expression:liver
RGD
PMID:24782632
RGD:14694831
NCBI chrNW_004955469:8,183,945...8,233,869
Ensembl chrNW_004955469:8,183,945...8,233,869
G
Hamp
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:liver (human) associated with iron overload;protein:increased expression:serum (human)
RGD
PMID:28051796 PMID:29871592
RGD:15042878 RGD:15042880
NCBI chrNW_004955468:4,576,080...4,577,591
Ensembl chrNW_004955468:4,575,510...4,577,649
G
Hfe
homeostatic iron regulator
ISO
DNA:missense mutation:cds:p.C282Y (human) DNA:missense mutation:CDS:p.H63D
RGD
PMID:9453491 PMID:11473047
RGD:1601452 RGD:8694420
NCBI chrNW_004955483:933,269...941,070
Ensembl chrNW_004955483:932,352...941,143
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
disease_progression
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:19913842 PMID:23117815
RGD:15045604 RGD:5508690
NCBI chrNW_004955425:25,362,165...25,380,611
Ensembl chrNW_004955425:25,359,884...25,380,745
G
Htr2a
5-hydroxytryptamine receptor 2A
treatment
ISO
RGD
PMID:35732081
RGD:401900606
NCBI chrNW_004955431:583,165...646,991
Ensembl chrNW_004955431:580,713...647,345
G
Ide
insulin degrading enzyme
ISO
RGD
PMID:26576191
RGD:13792804
NCBI chrNW_004955425:819,461...926,440
Ensembl chrNW_004955425:847,615...926,318
G
Ifi30
IFI30 lysosomal thiol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35654975
NCBI chrNW_004955524:3,229,024...3,230,955
Ensembl chrNW_004955524:3,229,257...3,231,825
G
Igf1
insulin like growth factor 1
susceptibility
ISO
associated with Fetal Growth Retardation;mRNA:increased expression:liver (rat)
RGD
PMID:24275070
RGD:12904726
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
G
Igf1r
insulin like growth factor 1 receptor
susceptibility
ISO
associated with Fetal Growth Retardation;mRNA:increased expression:liver (rat)
RGD
PMID:24275070
RGD:12904726
NCBI chrNW_004955416:26,101,090...26,382,660
Ensembl chrNW_004955416:26,102,628...26,382,666
G
Igfbp7
insulin like growth factor binding protein 7
disease_progression treatment
ISO
mRNA:increased expression:liver (human) mRNA:increased expression:liver (rat)
RGD
PMID:31397492 PMID:31805951 PMID:35312185 PMID:36034446
RGD:401960873 RGD:401960876 RGD:401960878 RGD:401960879
NCBI chrNW_004955447:14,048,834...14,110,264
Ensembl chrNW_004955447:14,047,732...14,108,414
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21115542
NCBI chrNW_004955580:1,053,823...1,069,802
Ensembl chrNW_004955580:1,053,823...1,069,802
G
Il10
interleukin 10
severity
ISO
associated with morbid obesity
RGD
PMID:25894568
RGD:14975151
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
G
Il13
interleukin 13
ISO
protein:increased expression:serum
RGD
PMID:18802068
RGD:4145478
NCBI chrNW_004955408:4,046,406...4,049,795
G
Il18
interleukin 18
severity treatment
ISO
protein:increased expression:plasma
RGD
PMID:20422882 PMID:24006666 PMID:28660148
RGD:14696664 RGD:14696674 RGD:8655964
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21664615
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
G
Il1b
interleukin 1 beta
no_association
ISO
DNA:SNPs:CDS:rs1143634 (human) CTD Direct Evidence: marker/mechanism DNA:SNPs:CDS:rs16944 (human)
RGD CTD
PMID:27730688 PMID:32613381
RGD:14975293
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Il1rn
interleukin 1 receptor antagonist
severity
ISO
associated with morbid obesity, protein:increased expression:serum (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22027586 PMID:35654975
RGD:14401582
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21664615
NCBI chrNW_004955408:4,058,052...4,065,999
G
Il6
interleukin 6
ISO
mRNA,protein:increased expression:liver,plasma DNA:SNPs:promoter:rs10499563, rs1800795 (human)
RGD
PMID:18510618 PMID:27730688
RGD:14975293 RGD:7829808
NCBI chrNW_004955410:25,079,835...25,084,390
G
Ins
insulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32613381
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
G
Insr
insulin receptor
treatment susceptibility
ISO
DNA:deletion:cds: (codon 306, exon 4) (mouse) DNA:deletion:cds:codon 306 in exon 4 (mouse)
RGD
PMID:28468951 PMID:29325294
RGD:14700929 RGD:14700932
NCBI chrNW_004955563:1,867,400...2,011,845
Ensembl chrNW_004955563:1,867,400...2,009,149
G
Irs1
insulin receptor substrate 1
ISO
RGD
PMID:20846698
RGD:6483014
NCBI chrNW_004955453:7,685,715...7,742,262
Ensembl chrNW_004955453:7,685,715...7,742,262
G
Irs2
insulin receptor substrate 2
ISO
RGD
PMID:20846698
RGD:6483014
NCBI chrNW_004955404:2,531,484...2,555,383
Ensembl chrNW_004955404:2,531,484...2,555,689
G
Jak2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18782535 PMID:28100771
RGD:6483030
NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208
G
Klb
klotho beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29289645
NCBI chrNW_004955443:7,917,047...7,954,390
Ensembl chrNW_004955443:7,917,585...7,954,322
G
Krt18
keratin 18
disease_progression
ISO
protein:increased expression:serum (human) protein:increased degradation:serum (rat) associated with Metabolic Syndrome; protein:increased expression:liver, serum (rat)
RGD
PMID:29989845 PMID:30089409 PMID:30149902 PMID:30839434
RGD:18337481 RGD:18337482 RGD:18337497 RGD:26884460
NCBI chrNW_004955458:227,017...230,752
Ensembl chrNW_004955458:226,805...232,728
G
Lama1
laminin subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21664615
NCBI chrNW_004955402:4,281,415...4,397,158
Ensembl chrNW_004955402:4,285,492...4,400,348
G
Ldlr
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20938947 PMID:23127599 PMID:23285030
NCBI chrNW_004955495:2,114,702...2,135,584
Ensembl chrNW_004955495:2,114,434...2,138,056
G
Lep
leptin
ISO
associated with Hepatitis C, Chronic;proteinLincreased expression:serum (human) CTD Direct Evidence: marker/mechanism OMIM:613282 | OMIM:613387 associated with type 2 diabetes mellitus;protein:increased expression:serum (human) associated with Type 2 Diabetes Mellitus;protein:increased expression:plasma
RGD CTD MouseDO
PMID:18713300 PMID:20476641 PMID:24211274 PMID:30052309 PMID:36105184
RGD:2311137 RGD:25330346 RGD:25330349
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
G
Lepr
leptin receptor
susceptibility
ISO
DNA:SNP:cds:p.Q223R(human) OMIM:613282 | OMIM:613387 DNA:intron:c.2673+1118C>T (rs6700896) (human)
RGD MouseDO
PMID:22215535 PMID:27257426
RGD:14696694 RGD:21079462
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
G
Lif
LIF interleukin 6 family cytokine
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21664615
NCBI chrNW_004955455:4,489,515...4,505,439
Ensembl chrNW_004955455:4,489,421...4,497,940
G
LOC102010322
cytochrome P450 1A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27565560
NCBI chrNW_004955450:3,165,107...3,171,894
Ensembl chrNW_004955450:3,165,106...3,171,942
G
LOC102011010
steroid 17-alpha-hydroxylase/17,20 lyase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15706422
NCBI chrNW_004955485:7,615,132...7,652,899
Ensembl chrNW_004955485:7,645,363...7,650,658
G
LOC102011841
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
ISO
protein:decreased expression:liver (mouse)
RGD
PMID:29710028
RGD:25671411
NCBI chrNW_004955458:5,472,404...5,477,001
Ensembl chrNW_004955458:5,472,404...5,477,001
G
LOC102021597
alpha-1-antiproteinase S-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35654975
NCBI chrNW_004955438:17,920,200...17,929,105
G
LOC102026028
cytochrome P450 2E1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:25317811 PMID:26428356 PMID:26703967 PMID:28458161
RGD:11573192 RGD:14700871 RGD:14700881
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
G
Lpl
lipoprotein lipase
treatment
ISO
RGD
PMID:27978932 PMID:30214514
RGD:13793398 RGD:13794377
NCBI chrNW_004955403:43,646,084...43,672,116
Ensembl chrNW_004955403:43,646,084...43,673,967
G
Mapk8
mitogen-activated protein kinase 8
treatment
ISO
associated with Diabetes Mellitus, Type 2; protein:increased phosphorylation:adipose tissue, liver (rat)
RGD
PMID:24404139 PMID:27909723
RGD:13506784 RGD:150340686
NCBI chrNW_004955556:1,593,552...1,705,543
Ensembl chrNW_004955556:1,593,494...1,665,784
G
Met
MET proto-oncogene, receptor tyrosine kinase
disease_progression
ISO
RGD
PMID:24845607
RGD:14694829
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
G
Mfn2
mitofusin 2
treatment
ISO
RGD
PMID:26401075
RGD:13204743
NCBI chrNW_004955486:1,937,873...1,962,577
Ensembl chrNW_004955486:1,937,802...1,962,772
G
Mlxipl
MLX interacting protein like
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004955456:14,096,530...14,116,687
Ensembl chrNW_004955456:14,096,531...14,117,269
G
Mthfr
methylenetetrahydrofolate reductase
severity susceptibility
ISO
DNA:SNP: :1298A > C (human) DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:17563923 PMID:24488901
RGD:14696706 RGD:14696748
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
G
Mttp
microsomal triglyceride transfer protein
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15094225 PMID:35654975
RGD:1581245
NCBI chrNW_004955496:7,963,323...8,022,393
Ensembl chrNW_004955496:7,963,262...8,009,838
G
Nampt
nicotinamide phosphoribosyltransferase
treatment
ISO
RGD
PMID:27982256
RGD:153352323
NCBI chrNW_004955410:10,717,664...10,742,109
Ensembl chrNW_004955410:10,717,664...10,751,177
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:23592516 PMID:25294219
RGD:10412712
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
G
Nlrp3
NLR family pyrin domain containing 3
ISO
OMIM:613282 | OMIM:613387
MouseDO
NCBI chrNW_004955581:597,952...616,903
Ensembl chrNW_004955581:597,667...617,410
G
Nos2
nitric oxide synthase 2
ISO
mRNA, protein:increased expression:liver (mouse)
RGD
PMID:21948338
RGD:5509578
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:28932253 PMID:29289645
RGD:13434914
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
G
Nr1h4
nuclear receptor subfamily 1 group H member 4
susceptibility treatment disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:deletion:cds:exon 9 (mouse) mRNA:increased expression:liver (rat) mRNA:decreased expression:liver (rat)
RGD CTD
PMID:23117815 PMID:23700488 PMID:29142166 PMID:29743187 PMID:30257410 PMID:32062620 More...
RGD:14696797 RGD:14701033 RGD:15045604 RGD:15090799
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
G
Nr5a2
nuclear receptor subfamily 5 group A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29515023
NCBI chrNW_004955406:36,263,257...36,415,494
Ensembl chrNW_004955406:36,263,184...36,415,525
G
Pdk4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29289645
NCBI chrNW_004955432:12,169,548...12,182,064
Ensembl chrNW_004955432:12,169,435...12,182,409
G
Pemt
phosphatidylethanolamine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29416063
NCBI chrNW_004955577:365,031...443,138
Ensembl chrNW_004955577:367,288...443,138
G
Pgrmc1
progesterone receptor membrane component 1
ISO
OMIM:613282 | OMIM:613387
MouseDO
NCBI chrNW_004955534:698,895...706,586
Ensembl chrNW_004955534:698,734...706,946
G
Phyh
phytanoyl-CoA 2-hydroxylase
treatment
ISO
RGD
PMID:29031784
RGD:13831310
NCBI chrNW_004955462:1,238,622...1,250,731
Ensembl chrNW_004955462:1,238,622...1,250,736
G
Pklr
pyruvate kinase L/R
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004955545:1,742,432...1,749,632
Ensembl chrNW_004955545:1,739,152...1,749,632
G
Pla2g7
phospholipase A2 group VII
ISO
protein:increased expression:serum
RGD
PMID:22112193
RGD:6482771
NCBI chrNW_004955437:11,534,251...11,577,942
Ensembl chrNW_004955437:11,534,173...11,555,996
G
Pnpla3
patatin like phospholipase domain containing 3
susceptibility
ISO
DNA:SNPs: : ClinVar Annotator: match by term: NAFLD1 | ClinVar Annotator: match by term: Susceptibility to Nonalcoholic Fatty Liver Disease
RGD ClinVar
PMID:18820647 PMID:21381068 PMID:24033266 PMID:24917523 PMID:25290313 PMID:26200108 PMID:26740948 PMID:27288299 PMID:28073161 PMID:28492532 PMID:29158695 More...
RGD:13463463
NCBI chrNW_004955413:28,879,646...28,896,224
Ensembl chrNW_004955413:28,879,748...28,893,938
G
Pon2
paraoxonase 2
treatment
ISO
RGD
PMID:22536512
RGD:8661257
NCBI chrNW_004955432:11,988,009...12,020,702
Ensembl chrNW_004955432:11,987,919...12,020,740
G
Ppara
peroxisome proliferator activated receptor alpha
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:23603006 PMID:31211621
RGD:14747028
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
G
Ppard
peroxisome proliferator activated receptor delta
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16574099 PMID:29289645
NCBI chrNW_004955437:3,285,281...3,354,099
Ensembl chrNW_004955437:3,288,830...3,357,048
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35654975
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
G
Ppargc1a
PPARG coactivator 1 alpha
treatment susceptibility
ISO
associated with Obesity; DNA:missense mutation:cds:p.G482S rs8192678 (human)
RGD
PMID:21373642 PMID:23269818 PMID:26394137
RGD:329955565 RGD:6484527 RGD:7241847
NCBI chrNW_004955480:543,397...1,188,376
Ensembl chrNW_004955480:1,078,322...1,188,435
G
Ppargc1b
PPARG coactivator 1 beta
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004955415:4,638,057...4,756,885
Ensembl chrNW_004955415:4,644,998...4,757,093
G
Ppdpf
pancreatic progenitor cell differentiation and proliferation factor
ISO
OMIM:613282 | OMIM:613387
MouseDO
NCBI chrNW_004955528:701,182...718,037
G
Prdx3
peroxiredoxin 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34678374
NCBI chrNW_004955431:23,640,775...23,651,738
Ensembl chrNW_004955431:23,638,765...23,652,191
G
Prf1
perforin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24211274
NCBI chrNW_004955437:20,700,912...20,705,076
Ensembl chrNW_004955437:20,700,718...20,706,929
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29341352
NCBI chrNW_004955415:32,794,172...32,807,944
Ensembl chrNW_004955415:32,793,718...32,812,930
G
Prkca
protein kinase C alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29341352
NCBI chrNW_004955478:5,686,639...6,090,356
Ensembl chrNW_004955478:5,686,640...6,083,967
G
Prkcd
protein kinase C delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29341352
NCBI chrNW_004955430:3,125,066...3,151,857
Ensembl chrNW_004955430:3,124,738...3,153,274
G
Prkce
protein kinase C epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29341352
NCBI chrNW_004955441:12,642,703...13,142,396
Ensembl chrNW_004955441:12,642,697...13,139,372
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26023714
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
G
Ptgs2
prostaglandin-endoperoxide synthase 2
treatment
ISO
RGD
PMID:26723251
RGD:11086779
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
G
Rag2
recombination activating 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24211274
NCBI chrNW_004955422:9,867,307...9,869,732
Ensembl chrNW_004955422:9,867,307...9,869,732
G
Rarres2
retinoic acid receptor responder 2
disease_progression
ISO
mRNA, protein:decreased expression:liver,serum mRNA:decreased expression:liver
RGD
PMID:23507574
RGD:15036822
NCBI chrNW_004955491:4,954,809...4,957,724
Ensembl chrNW_004955491:4,955,068...4,956,956
G
Rdx
radixin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29341352
NCBI chrNW_004955412:12,100,436...12,184,444
Ensembl chrNW_004955412:12,100,359...12,172,545
G
Retn
resistin
ISO
protein:increased expression:serum
RGD
PMID:20560816
RGD:7207249
NCBI chrNW_004955563:1,607,814...1,609,273
Ensembl chrNW_004955563:1,607,814...1,609,273
G
Samm50
SAMM50 sorting and assembly machinery component
ISO
DNA:SNPs: :
RGD
PMID:26740948
RGD:13463463
NCBI chrNW_004955413:28,901,124...28,925,093
Ensembl chrNW_004955413:28,901,124...28,925,093
G
Scarb1
scavenger receptor class B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23127599
NCBI chrNW_004955482:4,813,502...4,836,479
Ensembl chrNW_004955482:4,813,955...4,837,392
G
Serpinb2
serpin family B member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21664615
NCBI chrNW_004955402:47,707,182...47,720,688
Ensembl chrNW_004955402:47,711,215...47,720,755
G
Serpine1
serpin family E member 1
ISO
protein:increased expression:blood:
RGD
PMID:25091195
RGD:13208545
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
G
Sidt2
SID1 transmembrane family member 2
ISO
OMIM:613282 | OMIM:613387
MouseDO
NCBI chrNW_004955412:18,505,453...18,521,667
Ensembl chrNW_004955412:18,505,453...18,522,082
G
Sirt1
sirtuin 1
treatment severity
ISO
protein:decreased expression:liver associated with Obesity, Morbid;mRNA:decreased expression:visceral abdominal adipose tissue CTD Direct Evidence: therapeutic
RGD CTD
PMID:17498258 PMID:20033348 PMID:22902550 PMID:26026874
RGD:9585663 RGD:9585746 RGD:9586021
NCBI chrNW_004955425:20,280,725...20,307,663
Ensembl chrNW_004955425:20,279,963...20,307,663
G
Sirt2
sirtuin 2
treatment
ISO
associated with Obesity
RGD
PMID:22327056
RGD:9586049
NCBI chrNW_004955468:626,365...644,441
Ensembl chrNW_004955468:626,365...644,441
G
Sirt3
sirtuin 3
treatment
ISO
associated with Obesity
RGD
PMID:22327056
RGD:9586049
NCBI chrNW_004955476:11,794,951...11,826,244
Ensembl chrNW_004955476:11,794,951...11,826,237
G
Sirt4
sirtuin 4
ISO
RGD
PMID:20651844
RGD:9586052
NCBI chrNW_004955455:11,322,812...11,334,786
Ensembl chrNW_004955455:11,324,479...11,334,817
G
Sirt6
sirtuin 6
treatment
ISO
RGD
PMID:21373642
RGD:6484527
NCBI chrNW_004955495:4,641,883...4,650,518
Ensembl chrNW_004955495:4,644,023...4,650,083
G
Sod2
superoxide dismutase 2
treatment
ISO
RGD
PMID:15094225 PMID:24597775
RGD:11352823 RGD:1581245
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
G
Srebf1
sterol regulatory element binding transcription factor 1
disease_progression treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (mouse)
CTD RGD
PMID:23603006 PMID:24633463 PMID:26394137 PMID:29173234
RGD:329955565 RGD:401827867
NCBI chrNW_004955577:171,425...183,669
Ensembl chrNW_004955577:171,425...186,046
G
Stat3
signal transducer and activator of transcription 3
ISO
RGD
PMID:18782535
RGD:6483030
NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687
G
Stc2
stanniocalcin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097666
NCBI chrNW_004955408:25,937,174...25,950,221
Ensembl chrNW_004955408:25,934,932...25,949,399
G
Tff3
trefoil factor 3
treatment
ISO
RGD
PMID:31211621
RGD:14747028
NCBI chrNW_004955407:39,398,534...39,401,085
Ensembl chrNW_004955407:39,398,074...39,401,248
G
Tfrc
transferrin receptor
ISO
protein:increased expression:liver
RGD
PMID:23805238
RGD:11541090
NCBI chrNW_004955420:12,348,392...12,372,714
Ensembl chrNW_004955420:12,348,821...12,372,691
G
Tg
thyroglobulin
sexual_dimorphism
ISO
RGD
PMID:30016121
RGD:401976499
NCBI chrNW_004955461:7,487,268...7,703,458
Ensembl chrNW_004955461:7,487,322...7,703,363
G
Tgfb1
transforming growth factor beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21664615 PMID:32613381
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
G
Tlr4
toll like receptor 4
severity treatment
ISO
mRNA:increased expression:liver:
RGD
PMID:22253482 PMID:23301938 PMID:25413054
RGD:14700656 RGD:14700658 RGD:7777122
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
G
Tlr9
toll like receptor 9
ISO
mRNA:increased expression:liver (human, mouse)
RGD
PMID:28687713
RGD:18337289
NCBI chrNW_004955532:3,828,645...3,832,699
Ensembl chrNW_004955532:3,828,775...3,832,582
G
Tm6sf2
transmembrane 6 superfamily member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24531328
NCBI chrNW_004955524:2,586,201...2,593,123
Ensembl chrNW_004955524:2,585,797...2,593,105
G
Tnf
tumor necrosis factor
treatment severity
ISO
protein:increased expression:serum, liver (rat) CTD Direct Evidence: marker/mechanism associated with morbid obesity
RGD CTD
PMID:19034968 PMID:25219124 PMID:25894568 PMID:32613381
RGD:10450574 RGD:14975151 RGD:14995482
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Tnfaip3
TNF alpha induced protein 3
severity
ISO
RGD
PMID:27253414
RGD:151347600
NCBI chrNW_004955436:21,566,591...21,581,551
Ensembl chrNW_004955436:21,566,423...21,578,469
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20353583
NCBI chrNW_004955486:1,790,531...1,817,986
Ensembl chrNW_004955486:1,792,115...1,818,362
G
Trib1
tribbles pseudokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35654975
NCBI chrNW_004955461:494,003...501,928
Ensembl chrNW_004955461:494,003...501,990
G
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29289645
NCBI chrNW_004955597:259,209...265,896
Ensembl chrNW_004955597:260,790...265,326
G
Ucp2
uncoupling protein 2
treatment
ISO
mRNA, protein:increased expression:liver mRNA:increased expression:liver
RGD
PMID:18308829 PMID:18543254 PMID:21359922
RGD:7175312 RGD:7204434 RGD:7204435
NCBI chrNW_004955414:17,592,914...17,596,477
Ensembl chrNW_004955414:17,592,914...17,596,477
G
Vdr
vitamin D receptor
treatment
ISO
mRNA,protein:increased expression:hepatocyte:
RGD
PMID:27245430
RGD:14401753
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
G
Vldlr
very low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29289645
NCBI chrNW_004955434:7,013,092...7,050,103
Ensembl chrNW_004955434:7,013,092...7,050,103
G
Xbp1
X-box binding protein 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24097666 PMID:26394137
RGD:329955565
NCBI chrNW_004955455:3,037,885...3,041,827
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:serum:
RGD
PMID:27639593
RGD:14995335
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO
RGD
PMID:28770225
RGD:401940144
NCBI chrNW_004955457:7,424,403...7,490,630
Ensembl chrNW_004955457:7,431,736...7,491,149
G
Ggt1
gamma-glutamyltransferase 1
ISO
protein:increased expression:serum:
RGD
PMID:23730648
RGD:14747013
NCBI chrNW_004955455:8,082,578...8,099,523
G
Gpt
glutamic--pyruvic transaminase
ISO
protein:increased expression:liver,serum
RGD
PMID:18710424
RGD:14975250
NCBI chrNW_004955454:3,127,997...3,132,459
Ensembl chrNW_004955454:3,127,997...3,132,459
G
Gpt2
glutamic--pyruvic transaminase 2
ISO
protein:increased expression:liver,serum
RGD
PMID:18710424
RGD:14975250
NCBI chrNW_004955474:8,248,622...8,285,449
Ensembl chrNW_004955474:8,250,759...8,285,227
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
associated with morbid obesity;mRNA:decreased expression:liver
RGD
PMID:33081272
RGD:401900305
NCBI chrNW_004955431:583,165...646,991
Ensembl chrNW_004955431:580,713...647,345
G
Htr2b
5-hydroxytryptamine receptor 2B
ISO
associated with morbid obesity;mRNA:decreased expression:liver
RGD
PMID:33081272
RGD:401900305
NCBI chrNW_004955453:4,352,278...4,367,807
Ensembl chrNW_004955453:4,351,668...4,367,807
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
susceptibility severity
ISO
RGD
PMID:29861476 PMID:31064654
RGD:14985251 RGD:14985252
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
G
Ngf
nerve growth factor
ISO
protein:increased expression:plasma
RGD
PMID:22434756
RGD:401976546
NCBI chrNW_004955435:18,581,889...18,633,330
Ensembl chrNW_004955435:18,581,808...18,601,059
G
Nr1h4
nuclear receptor subfamily 1 group H member 4
severity
ISO
cholic acid fed FXR-/- mouse
RGD
PMID:12971955
RGD:15045573
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
G
Alb
albumin
treatment
ISO
RGD
PMID:25162205
RGD:14694843
NCBI chrNW_004955447:9,327...21,212
G
Txnip
thioredoxin interacting protein
ISO
MouseDO
NCBI chrNW_004955568:103,801...107,791
Ensembl chrNW_004955568:103,762...107,785
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all